Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Dermatologia
Roma, Italia, 00168, Italy
Location status: Recruiting
Location contact
Giacomo Caldarola, MD
CONTACT
Giacomo Caldarola, MD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06801821
Primary objective:
The primary objective is to evaluate in the general population the difference between emotional reactions associated with facial involvement by four major dermatologic diseases: psoriasis, atopic dermatitis, vitiligo, and alopecia areata.
* Compare the social distance and stereotyping by the general population toward individuals with facial involvement by: psoriasis, atopic dermatitis, vitiligo, and alopecia areata. * Evaluate demographic factors that describe a greater tendency toward stigmatization.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Roma, Italia, 00168, Italy
Location status: Recruiting
Giacomo Caldarola, MD
CONTACT
Giacomo Caldarola, MD
PRINCIPAL_INVESTIGATOR
Basic demographic characteristics (Gender, Age, Employment status, Education level) will be recorded for each patient.
Participants will be asked to observe images depicting faces of individuals with atopic dermatitis, alopecia areata, vitiligo, and psoriasis (generated through artificial intelligence systems). They will be asked to select the individual from those shown that generates the most compassion/pity, disgust, blame/disapproval/disdain, and curiosity for them, analyzing the same emotional responses investigated in a study on stigma toward psoriasis patients.
In addition, each participant will be given a 14-question questionnaire on stigma (analyzing social distance and stereotyping) toward one of the four diseases under investigation (psoriasis, atopic dermatitis, vitiligo, or alopecia areata), selected randomly. For each question, responses will be expressed from 1 to 5, on a Likert scale, with lower scores indicating greater stigma. (Total score between 14 and 70)
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 12 months
Compare the percentage of patients associating the 4 different emotional reactions analyzed (compassion/pity, disgust, blame/disapproval/dislike, and curiosity) with each dermatologic condition under study.
Contact information is provided by the study sponsor or research team.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Other
Acronym: STIGMADERM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07455578
Arthritis, Arthritis, Psoriatic
Charlestown, New South Wales, Australia
View Trial DetailsNCT06982352
Atopic Dermatitis (AD), Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Fargo, North Dakota, United States
View Trial DetailsNCT07021495
Abscess, Angioedema
Nijmegen, Gelderland, Netherlands
View Trial DetailsNCT07390487
Anxiety, Anxiety Disorders
San Francisco, California, United States
View Trial Details